COVID-19 Resources

As we all work to navigate the impact of COVID-19 on the health care sector and how care is delivered, ASPL wants to ensure our members have access to valuable resources to help you manage guidance being issued related to this pandemic.  If your organization has resources it would like to share, please forward the information to [email protected].

National Alliance of State Pharmacy Associations - https://naspa.us/resource/covid-19-information-from-the-states/
Bula Intelligence - Bula Blog
Faegre Drinker - Coronavirus (COVID-19) Resource Center
Hall Render - COVID-19 Resource Center
National Alliance of State Pharmacy Associations - COVID-19 State Rulings
National Association of Boards of Pharmacy - COVID-19 Resource Center
Quarles & Brady - COVID-19: Guidance for Clients

 

 

The American Society for Pharmacy Law (ASPL) is an organization of attorneys, pharmacists, pharmacist-attorneys and students of pharmacy or law who are interested in the law as it applies to pharmacy, pharmacists, wholesalers, manufacturers, state and federal government and other interested parties.

ASPL is a nonprofit organization with the purposes of

  • Furthering knowledge in the law related to pharmacists, pharmacies, the provision of pharmaceutical care, the manufacturing and distribution of drugs, and other food, drug, and medical device policy issues;
  • Communicating accurate legal educational information; and
  • Providing educational opportunities for pharmacists, attorneys, and others who are interested in pharmacy law

Latest News

June 3, 2020

FDA
FDA publishes 3 notices on the Orange Book regarding improved access and seeks stakeholder input

2020 marks the 40th anniversary of the Orange Book, or “Approved Drug Products with Therapeutic Equivalence Evaluations.” On May 31,  the FDA published several notices regarding the Orange Book and FDA’s attempts to make the publication more accessible. In addition, FDA is seeking stakeholder input on how to properly list patents in the Orange Book. The FDA Law Blog published a detailed review of these notices on May 31. [Koblitz SW, Karst KR. Squeezing all the juice from the Orange Book: FDA issues guidance and seeks comment. FDA Law Blog, 31 May 2020; https://bit.ly/2AAgryS]